Values as of: 2024-11-13
COMMON STOCK | Farm Products |
Last Closing
USD 25.77Change
-0.07 (-0.27)%Market Cap
USD 0.20BVolume
0.03MAnalyst Target
USD 38.00Verdict
Verdict
Alico, Inc., together with its subsidiaries, operates as an agribusiness and land management company in the United States. The company operates in two segments, Alico Citrus, and Land Management and Other Operations. The Alico Citrus segment engages in planting, owning, cultivating, and/or managing citrus groves to produce fruit for sale to fresh and processed citrus markets, including activities related to the purchase and resale of fruit and value-added services, which include contracting for the harvesting, marketing, and hauling of citrus. The Land Management and Other Operations segment is involved in the activities related to native plant sales, grazing and hunting leasing, management, and/or conservation of unimproved native pastureland; and activities related to rock mining royalties and other insignificant lines of business, as well as in the activities related to owning and/or leasing improved farmland. The company was incorporated in 1960 and is based in Fort Myers, Florida. Address: 10070 Daniels Interstate Court, Fort Myers, FL, United States, 33913
Company Website : https://www.alicoinc.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| CALM | Cal-Maine Foods Inc |
-1.57 (-1.69%) |
USD 4.27B |
| VITL | Vital Farms Inc |
+0.07 (+0.25%) |
USD 1.49B |
| CHSCO | CHS Inc CO Pref |
+0.09 (+0.34%) |
USD 0.58B |
| CHSCL | CHS Inc CL Pref |
+0.06 (+0.23%) |
USD 0.56B |
| CHSCM | CHS Inc CM Pref |
-0.03 (-0.10%) |
USD 0.51B |
| LMNR | Limoneira Co |
-0.21 (-0.77%) |
USD 0.46B |
| CHSCN | CHS Inc CN Pref |
+0.05 (+0.20%) |
USD 0.44B |
| CHSCP | CHS Inc Pref |
+0.07 (+0.24%) |
USD 0.34B |
| AFRI | Forafric Global PLC Ordinary S.. |
+0.02 (+0.19%) |
USD 0.28B |
| VFF | Village Farms International In.. |
-0.01 (-1.24%) |
USD 0.09B |
N/A
| Market Performance vs. Industry/Classification (Farm Products) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -11.38% | 33% | F | 36% | F | ||
| Dividend Return | 0.52% | 13% | F | 9% | A- | ||
| Total Return | -10.87% | 38% | F | 36% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -6.56% | 45% | F | 35% | F | ||
| Dividend Return | 0.73% | 13% | F | 9% | A- | ||
| Total Return | -5.84% | 45% | F | 34% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | -18.35% | 36% | F | 38% | F | ||
| Dividend Return | 13.05% | 25% | F | 50% | F | ||
| Total Return | -5.29% | 36% | F | 39% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -1.18% | 35% | F | 36% | F | ||
| Dividend Return | 1.71% | 45% | F | 39% | F | ||
| Total Return | 2.89% | 25% | F | 65% | D | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 20.07% | 70% | C- | 76% | C+ | ||
| Risk Adjusted Return | 8.51% | 55% | F | 41% | F | ||
| Market Capitalization | 0.20B | 53% | F | 48% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company had positive total free cash flow in the most recent four quarters.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
The company had negative total cash flow in the most recent four quarters.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
This stock has shown below median revenue growth in the previous 5 years compared to its sector
